Replies to post #24381 on Mymetics Corp (MYMX)

[bow-tie]

Award Information | HHS TAGGS
taggs.hhs.gov › Detail › AwardDetail
Apr 14, 2021 · To improve immunogenicity, Mymetics has embedded the toll-like receptor (TLR)7/8 adjuvant 3M-052 into virosomal envelopes. Moreover, Mymetics has developed a powdered form of virosomes that is no longer cold-chain dependent and can be administered as intranasal (IN) spray, sublingual (SL) tablets, or packaged into oral capsules.